The seemingly disparate roles of TRAF6 in AD support the need for high-quality small molecules that modulate this E3 ligase and would allow for better characterization of its diverse functions in inflammation, neuronal viability, and spinogenesis. This evidence concerns the gene TRAF6 and Alzheimer disease.